NR4A1 and breast carcinoma: The majority of cases were identified as hormone-receptor positive (HR+) (AA: 71%; EA: 72%; EAA: 65%; HL: 65%), and the prevalence across ancestries was comparable to the latest SEER registry showing that 70% of breast cancer subtypes are HR+.12